Epsilon M&A Deal Report - Non-Core OTC Brands of GlaxoSmithKline

Transaction Multiples for the Valuation of Private Companies

Omega Pharma > Non-Core OTC Brands of GlaxoSmithKline

Announced Date : 15 March 2012

Type : Acquisition of Majority Stake

Deal Value : Yes

Acquirer : Omega Pharma

Target: Non-Core OTC Brands of GlaxoSmithKline

Target Country: Germany

Sector of activity : Health, Pharmaceuticals & Biotechnology, Food & Beverage Industry

Business Description :

> Non-Core OTC Brands of GlaxoSmithKline is a portf ...

No EMAT : 80635

Transaction multiples available

	EV/Sales	EV/Gross Profit	EV/EBITDA	EV/EBIT	Eq/PBT	P/E	Price to Book
Historic
Current

: Multiple available

n.s : Multiple calculated, but not significant

Rating ***

Source: Epsilon Research / EMAT

Comparable Transactions

Number of EMAT Reports : (Food & Beverage Industry) = 743

Example of comparable transactions on EMAT (same sub-sector):

Date	Acquirer	Target	Country	Multiples	See details
31/05/2016	Recordati	Italchimici	Italy	0
17/05/2016	Private Group led by Vertis SGR	Preziosi Food	Italy	0

Source: Epsilon Research / EMAT

View Report

This report is accessible on EMAT, the reference database for private company acquisition multiples

Example of EMAT Report : click here

View Complete Report

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

Sectors covered by our analysts

Studies & indices published by Epsilon Research Register to receive (free) publications updates

EMAT Report

Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

Subscribe to EMAT database